Similar Articles

The Metabolic Syndrome: A Cancer Risk Factor?

Ayça Nur Demir, Kerem Can Tunç, Mehtap Odabaşı, Oytun Erbaş

DOI: 10.5606/jebms.2023.1040

Issue: 2023, Volume 4 - Issue 1
569 533

Emerging Immunotherapeutic Approaches for Managing Metastasis

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2023.1050

Issue: 2023, Volume 4 - Issue 2
490 449

Nasopharyngeal Carcinoma: Causes and Incidence

Fatih Özgür Sarıbıyık, Oytun Erbaş

DOI: 10.5606/jebms.2023.1060

Issue: 2023, Volume 4 - Issue 3
424 318

Regulatory T Cells and Their Implications in Cancer Immunotherapy

Saime Sıla Gemici, Oytun Erbaş

DOI: 10.5606/jebms.2023.1064

Issue: 2023, Volume 4 - Issue 3
321 346

Cancer Stem Cells

Alper Demirezen, Oytun Erbaş

DOI: 10.5606/jebms.2024.1083

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
367 278

Stem Cell Therapy in Cancer

Ayça Nur Demir, Oytun Erbaş

DOI: 10.5606/jebms.2024.1084

Issue: 2024, Volume 5 - Issue SPECIAL ISSUE
308 282

Enteral Nutrition in Cancer Patients

Gamze Nur Yüksel, Oytun Erbaş

DOI: 10.5606/jebms.2024.1089

Issue: 2024, Volume 5 - Issue 2
228 396

Coffee Intake and Cancer Risk: Exploring the Relationship

Zehra Betül Aydın, Oytun Erbaş

DOI: 10.5606/jebms.2024.1091

Issue: 2024, Volume 5 - Issue 2
232 384

Aspirin and NSAIDs as Cancer Preventive Agents: A Review

Nadin Bedikyan, Oytun Erbaş

DOI: 10.5606/jebms.2024.1093

Issue: 2024, Volume 5 - Issue 2
245 397